Media coverage about Nu Skin Enterprises (NYSE:NUS) has trended somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Nu Skin Enterprises earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.9649486040102 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern’s scoring:
- Nu Skin (NUS) Up 2.4% on Raised Q3 Sales and Profit View – Nasdaq (nasdaq.com)
- Nu Skin gives profits guidance a face-lift (proactiveinvestors.co.uk)
- NU SKIN ENTERPRISES INC : Results of Operations and Financial Condition (form 8-K) (4-traders.com)
- Nu Skin Enterprises, Inc. (NUS) Issues Q3 Earnings Guidance (americanbankingnews.com)
Nu Skin Enterprises (NYSE:NUS) opened at 63.87 on Monday. The firm has a 50 day moving average price of $61.77 and a 200-day moving average price of $59.36. Nu Skin Enterprises has a 12 month low of $46.35 and a 12 month high of $65.85. The firm has a market capitalization of $3.38 billion, a price-to-earnings ratio of 21.36 and a beta of 1.40.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.08. The firm had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The company’s revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 EPS. On average, equities analysts forecast that Nu Skin Enterprises will post $3.22 EPS for the current year.
A number of analysts have recently issued reports on the company. Zacks Investment Research cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the stock a “sell” rating in a report on Thursday, August 3rd. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Bank of America Corporation upped their price target on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a report on Monday, July 10th. Two analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. Nu Skin Enterprises currently has a consensus rating of “Hold” and a consensus price target of $62.00.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/10/16/nu-skin-enterprises-nus-receives-media-impact-rating-of-0-09.html.
In other Nu Skin Enterprises news, President Ryan S. Napierski sold 6,933 shares of the firm’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total value of $443,712.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Daniel W. Campbell sold 4,607 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $62.48, for a total value of $287,845.36. Following the completion of the sale, the director now directly owns 63,753 shares in the company, valued at approximately $3,983,287.44. The disclosure for this sale can be found here. Insiders sold a total of 27,040 shares of company stock worth $1,708,157 in the last ninety days. Insiders own 5.20% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.